Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Acacia Diversified Holdings, Inc. ACCA OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
30/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Acacia Diversified Holdings, Inc. (ACCA) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 27/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net profit margin is 0% (thin). Gross margin is 4.9% (+0 pp trend).

Balance sheet: total debt is $0 against $0 equity. Total assets: $0.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 50/100 (Fail), Moat 11/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

ACCA SharesGrow Score Overview

40/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 11/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ACCA

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
ACCA: -100%/yr revenue is, +100%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
50/100
Balance sheet ACCA: Debt-to-Equity (D/E) ratio N/A, Current ratio is N/A. Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
11/100
ACCA: Gross margin is 4.9% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 11/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range1.0E-4-2.0E-4
Volume6.7K
Avg Volume (30D)6.48K
Market Cap$5.43K
Beta (1Y)-0.55
Share Statistics
IPO Date2010-08-26
Employees5
CEOJeffery D. Bearden
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS00389L1044

Price Chart

Track all markets on TradingView
ACCA
Acacia Diversified Holdings, Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic

People Also View

CURLF
CURLF
Curaleaf Holdings, Inc.
$2.40
+0.04%
 GTBIF
GTBIF
Green Thumb Industries Inc.
$6.76
+0.30%
 TCNNF
TCNNF
Trulieve Cannabis Corp.
$6.47
+2.73%
 CRON
CRON
Cronos Group Inc.
$2.57
+0.78%
 CCHWF
CCHWF
Columbia Care Inc.
$0.94
-21.71%
 CGC
CGC
Canopy Growth Corporation
$1.09
+0.93%
 VRNOF
VRNOF
Verano Holdings Corp.
$1.30
+8.33%
 ACB
ACB
Aurora Cannabis Inc.
$3.53
+1.44%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message